Abstract | PURPOSE:
Androgen refractory prostate cancer is a major clinical challenge. Treatment approaches to prostate cancer are based on various mechanisms that cause malignant cell apoptosis. Of these strategies the anticancer effect of triggering death receptors is well substantiated. MATERIALS AND METHODS: RESULTS: CONCLUSIONS:
|
Authors | Yi-Cheng Chen, Fan-Lu Kung, Ian-Lih Tsai, Tsung-Hsien Chou, Ih-Sheng Chen, Jih-Hwa Guh |
Journal | The Journal of urology
(J Urol)
Vol. 183
Issue 6
Pg. 2409-18
(Jun 2010)
ISSN: 1527-3792 [Electronic] United States |
PMID | 20403609
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Androgens
- Pyrones
- Receptors, Death Domain
- cryptocaryone
|
Topics |
- Androgens
- Apoptosis
(drug effects)
- Drug Screening Assays, Antitumor
- Humans
- Male
- Membrane Microdomains
(drug effects, physiology)
- Prostatic Neoplasms
(pathology)
- Pyrones
(pharmacology)
- Receptors, Death Domain
(drug effects, physiology)
- Tumor Cells, Cultured
|